help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adamo, M.
Right arrow Articles by LeRoith, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adamo, M.
Right arrow Articles by LeRoith, D.

Endocrinology, Vol 123, 2565-2570, Copyright © 1988 by Endocrine Society


ARTICLES

Dexamethasone reduces steady state insulin-like growth factor I messenger ribonucleic acid levels in rat neuronal and glial cells in primary culture

M Adamo, H Werner, W Farnsworth, CT Roberts Jr, M Raizada and D LeRoith
Diabetes Branch, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, Maryland 20892.

Insulin-like growth factor I (IGF-I) mRNA was demonstrated in primary cultures of neuronal and glial cells from rat brain. On Northern blots, a rat IGF-I cDNA probe hybridized to RNA species of 7.5, 1.7, and 0.8- 1.2 kilobases in total and poly(A)+ RNA from both cell types. Solution hybridization/RNase protection assays were performed using an antisense riboprobe complementary to the 5'-untranslated region as well as part of the coding region of rat IGF-I mRNA. These studies indicated that two of the previously described three possible alternative 5'- untranslated splicing variants (classes A and C) were expressed in neuronal and glial cells, with class C transcripts predominating. Neuronal cells also possessed extremely low levels of class B transcripts. Treatment of neuronal cell cultures with the synthetic glucocorticoid dexamethasone reduced IGF-I mRNA levels by 60%. Glial cell IGF-I mRNA levels were reduced by dexamethasone by up to 40%. These results suggest that glucocorticoid-induced reductions in IGF-I production could occur at the level of transcription and may underlie some of the actions of glucocorticoids in causing growth retardation and inhibition of cell proliferation.


This article has been cited by other articles:


Home page
EndocrinologyHome page
O. Schakman, S. Kalista, L. Bertrand, P. Lause, J. Verniers, J. M. Ketelslegers, and J. P. Thissen
Role of Akt/GSK-3{beta}/{beta}-Catenin Transduction Pathway in the Muscle Anti-Atrophy Action of Insulin-Like Growth Factor-I in Glucocorticoid-Treated Rats
Endocrinology, August 1, 2008; 149(8): 3900 - 3908.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. M. Niblock, J. K. Brunso-Bechtold, and D. R. Riddle
Insulin-Like Growth Factor I Stimulates Dendritic Growth in Primary Somatosensory Cortex
J. Neurosci., June 1, 2000; 20(11): 4165 - 4176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. G. Burrin, T. J. Wester, T. A. Davis, M. L. Fiorotto, and X. Chang
Dexamethasone inhibits small intestinal growth via increased protein catabolism in neonatal pigs
Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E269 - E277.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Ye, Y. Umayahara, D. Ritter, T. Bunting, H. Auman, P. Rotwein, and A. J. D'Ercole
Regulation of Insulin-Like Growth Factor I (IGF-I) Gene Expression in Brain of Transgenic Mice Expressing an IGF-I-Luciferase Fusion Gene
Endocrinology, December 1, 1997; 138(12): 5466 - 5475.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society